COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
09/04/2025
SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at [...]
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
09/04/2025
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announces its newest effort: Tevogen Generics . This effort is in response to the growing [...]
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
09/04/2025
CHICAGO, April 09, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
09/04/2025
COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2024 was adopted. The Board of Directors’ proposal to transfer [...]
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
09/04/2025
COPENHAGEN, Denmark, April 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2024 was adopted. The Board of Directors’ proposal to transfer [...]
Patrick ALEXANDRE, Fondateur et PDG, revient sur le point d’étape publié lors de la présentation des comptes annuels 2024
09/04/2025
Communiqué de presse Patrick ALEXANDRE, Fondateur et PDG, revient sur le point d’étape publié lors de la présentation des comptes annuels 2024 Dijon, France le 09 avril 2025 (17h35 CET) -- CROSSJECT (ISIN: FR0011716265 [...]
Virbac : Declaration of the number of shares and voting rights 03/2025
09/04/2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote 03/2025
09/04/2025
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
JAAD Publishes Study on AVAVA’s Focal Point Technology™, A Breakthrough in Laser Treatments for All Skin Tones
09/04/2025
Peer-Reviewed Research Validates AVAVA’s Revolutionary Approach to Aesthetic Laser Treatments BOSTON and NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- AVAVA, a leader in medical aesthetics innovation, recently published [...]
Oxford Healthspan’s Primeadine® Supplement Expands U.S. Presence as a Leader in Longevity and Cell Renewal
09/04/2025
Visit Booth G24 at the Health Optimisation Summit in Austin to Learn More AUSTIN, Texas, April 09, 2025 (GLOBE NEWSWIRE) -- Oxford Healthspan , a pioneer in developing science-backed, food-derived longevity supplements [...]
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
09/04/2025
Strategic Combination Intended to Drive Advanced AI-Driven Drug Development and Expand Precision Medicine Applications Across Cancer and Neurology LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc [...]
Merit Medical Launches the Ventrax™ Delivery System
09/04/2025
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a [...]
Better Choice Company Regains Compliance with NYSE American Continued Listing Standards
09/04/2025
TAMPA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it received formal notice [...]
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
09/04/2025
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio ( [...]
Imprivata Introduces New Advanced Analytics Solution to Deliver Key Security and Operational Insights into Enterprise Mobile Device Usage
09/04/2025
Imprivata Mobile Access Management now offers enhanced analytics to provide in-depth mobile workflow analysis to optimize resource allocation, improve user efficiency, and drive ROI of mobile initiatives WALTHAM, Mass [...]
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV
09/04/2025
MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. ( OTC: FITY ) , through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug discovery, and UAV Corp ( [...]
Privia Health Enters Arizona In Partnership with Integrated Medical Services
09/04/2025
IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15 th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., April 09, 2025 (GLOBE NEWSWIRE) -- [...]
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
09/04/2025
David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- [...]
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
09/04/2025
SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today announced that it [...]

Pages